300
Views
3
CrossRef citations to date
0
Altmetric
Review

Treatment of unruptured intracranial aneurysms: a review

, , , &
Pages 1205-1216 | Received 07 Jul 2015, Accepted 07 Jun 2016, Published online: 04 Jul 2016

References

  • Vlak MH, Algra A, Brandenburg R, et al. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol. 2011;10(7):626–636.
  • Inagawa T, Ishikawa S, Aoki H, et al. Aneurysmal subarachnoid hemorrhage in Izumo City and Shimane Prefecture of Japan. Incidence. Stroke J Cereb Circ. 1988;19(2):170–175.
  • Stehbens WE. Aneurysms and anatomical variation of cerebral arteries. Arch Pathol. 1963;75:45–64.
  • Chason JL, Hindman WM. Berry aneurysms of the circle of Willis: results of a planned autopsy study. Neurology. 1958;8(1):41–41.
  • Cohen MM. Cerebrovascular accidents; a study of two hundred one cases. AMA Arch Pathol. 1955;60(3):296–307.
  • Crompton MR. Mechanism of growth and rupture in cerebral berry aneurysms. Br Med J. 1966;1(5496):1138–1142.
  • de la Monte SM, Moore GW, Monk MA, et al. Risk factors for the development and rupture of intracranial berry aneurysms. Am J Med. 1985;78(6 Pt 1):957–964.
  • McCormick WF, Acosta-Rua GJ. The size of intracranial saccular aneurysms. An autopsy study. J Neurosurg. 1970;33(4):422–427.
  • Brown RD, Broderick JP. Unruptured intracranial aneurysms: epidemiology, natural history, management options, and familial screening. Lancet Neurol. 2014;13(4):393–404.
  • Rinkel GJ, Djibuti M, Algra A, et al. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke J Cereb Circ. 1998;29(1):251–256.
  • Wermer MJH, van der Schaaf IC, Algra A, et al. Risk of rupture of unruptured intracranial aneurysms in relation to patient and aneurysm characteristics: an updated meta-analysis. Stroke. 2007;38(4):1404–1410.
  • Linn FH, Rinkel GJ, Algra A, et al. Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke J Cereb Circ. 1996;27(4):625–629.
  • Ronkainen A, Miettinen H, Karkola K, et al. Risk of harboring an unruptured intracranial aneurysm. Stroke J Cereb Circ. 1998;29(2):359–362.
  • Unruptured intracranial aneurysms–risk of rupture and risks of surgical intervention. International Study of Unruptured Intracranial Aneurysms Investigators. N Engl J Med. 1998; 339(24): 1725–1733.
  • Wiebers DO, Whisnant JP, Huston J, et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003;362(9378):103–110.
  • UCAS Japan Investigators, Morita A, Kirino T, et al. The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med. 2012; 366(26):2474–2482.
  • Juvela S, Poussa K, Lehto H, et al. Natural history of unruptured intracranial aneurysms: a long-term follow-up study. Stroke J Cereb Circ. 2013;44(9):2414–2421.
  • Kassell NF, Torner JC. Size of intracranial aneurysms. Neurosurgery. 1983;12(3):291–297.
  • Ishibashi T, Murayama Y, Urashima M, et al. Unruptured intracranial aneurysms: incidence of rupture and risk factors. Stroke J Cereb Circ. 2009;40(1):313–316.
  • Sonobe M, Yamazaki T, Yonekura M, et al. Small unruptured intracranial aneurysm verification study: SUAVe study, Japan. Stroke J Cereb Circ. 2010;41(9):1969–1977.
  • Greving JP, Wermer MJH, Brown RD, et al. Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies. Lancet Neurol. 2014;13(1):59–66.
  • Huttunen T, von und zu Fraunberg M, Frösen J, et al. Saccular intracranial aneurysm disease: distribution of site, size, and age suggests different etiologies for aneurysm formation and rupture in 316 familial and 1454 sporadic eastern Finnish patients. Neurosurgery. 2010;66(4):631–638; discussion 638.
  • Ghods AJ, Lopes D, Chen M. Gender differences in cerebral aneurysm location. Front Neurol. 2012;3:78.
  • Tada Y, Wada K, Shimada K, et al. Estrogen protects against intracranial aneurysm rupture in ovariectomized mice. Hypertension. 2014;63(6):1339–1344.
  • Etminan N, Beseoglu K, Steiger H-J, et al. The impact of hypertension and nicotine on the size of ruptured intracranial aneurysms. J Neurol Neurosurg Psychiatry. 2011;82(1):4–7.
  • Chalouhi N, Ali MS, Starke RM, et al. Cigarette smoke and inflammation: role in cerebral aneurysm formation and rupture. Mediators Inflamm. 2012;2012:271582.
  • Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ. 1989;298(6676):789–794.
  • Neil-Dwyer G, Bartlett JR, Nicholls AC, et al. Collagen deficiency and ruptured cerebral aneurysms. A clinical and biochemical study. J Neurosurg. 1983;59(1):16–20.
  • Suga M, Yamamoto Y, Sunami N, et al. [Rupture of previously documented asymptomatic unruptured aneurysms–aneurysm size: risk factor for aneurysm rupture]. No Shinkei Geka. 2002;30(6):609–615.
  • Yasui N, Suzuki A, Nishimura H, et al. Long-term follow-up study of unruptured intracranial aneurysms. Neurosurgery. 1997;40(6):1155–1159; discussion 1159–1160.
  • Beck J, Rohde S, el Beltagy M, et al. Difference in configuration of ruptured and unruptured intracranial aneurysms determined by biplanar digital subtraction angiography. Acta Neurochir (Wien). 2003;145(10):861–865; discussion 865.
  • Hademenos GJ, Massoud TF, Turjman F, et al. Anatomical and morphological factors correlating with rupture of intracranial aneurysms in patients referred for endovascular treatment. Neuroradiology. 1998;40(11):755–760.
  • Ma B, Harbaugh RE, Raghavan ML. Three-dimensional geometrical characterization of cerebral aneurysms. Ann Biomed Eng. 2004;32(2):264–273.
  • Sadatomo T, Yuki K, Migita K, et al. Morphological differences between ruptured and unruptured cases in middle cerebral artery aneurysms. Neurosurgery. 2008;62(3):602–609; discussion 602–609.
  • Dhar S, Tremmel M, Mocco J, et al. Morphology parameters for intracranial aneurysm rupture risk assessment. Neurosurgery. 2008;63(4):185–196; discussion 196–197.
  • Ujiie H, Tamano Y, Sasaki K, et al. Is the aspect ratio a reliable index for predicting the rupture of a saccular aneurysm? Neurosurgery. 2001;48(3):495–502; discussion 502–503.
  • Weir B, Amidei C, Kongable G, et al. The aspect ratio (dome/neck) of ruptured and unruptured aneurysms. J Neurosurg. 2003;99(3):447–451.
  • Nader-Sepahi A, Casimiro M, Sen J, et al. Is aspect ratio a reliable predictor of intracranial aneurysm rupture? Neurosurgery. 2004;54(6):1343–1347; discussion 1347–1348.
  • Tremmel M, Dhar S, Levy EI, et al. Influence of intracranial aneurysm-to-parent vessel size ratio on hemodynamics and implication for rupture: results from a virtual experimental study. Neurosurgery. 2009;64(4):622–630; discussion 630–631.
  • Ambekar S, Madhugiri V, Bollam P, et al. Morphological differences between ruptured and unruptured basilar bifurcation aneurysms. J Neurol Surg Part B Skull Base. 2013;74(2):91–96.
  • Lüscher TF, Tanner FC. Endothelial regulation of vascular tone and growth. Am J Hypertens. 1993;6(7 Pt 2):283S–293S.
  • Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell. 1994;78(6):931–936.
  • Kadirvel R, Ding Y-H, Dai D, et al. The influence of hemodynamic forces on biomarkers in the walls of elastase-induced aneurysms in rabbits. Neuroradiology. 2007;49(12):1041–1053.
  • Kaiser D, Freyberg MA, Friedl P. Lack of hemodynamic forces triggers apoptosis in vascular endothelial cells. Biochem Biophys Res Commun. 1997;231(3):586–590.
  • Wang F, Xu B, Sun Z, et al. Wall shear stress in intracranial aneurysms and adjacent arteries. Neural Regen Res. 2013;8(11):1007–1015.
  • Xiang J, Natarajan SK, Tremmel M, et al. Hemodynamic-morphologic discriminants for intracranial aneurysm rupture. Stroke J Cereb Circ. 2011;42(1):144–152.
  • Schneiders JJ, Marquering HA, van den Berg R, et al. Rupture-associated changes of cerebral aneurysm geometry: high-resolution 3D imaging before and after rupture. AJNR Am J Neuroradiol. 2014;35(7):1358–1362.
  • Takao H, Murayama Y, Otsuka S, et al. Hemodynamic differences between unruptured and ruptured intracranial aneurysms during observation. Stroke J Cereb Circ. 2012;43(5):1436–1439.
  • Backes D, Vergouwen MDI, Tiel Groenestege AT, et al. PHASES score for prediction of intracranial aneurysm growth. Stroke J Cereb Circ. 2015;46(5):1221–1226.
  • Etminan N, Brown RD, Beseoglu K, et al. The unruptured intracranial aneurysm treatment score: a multidisciplinary consensus. Neurology. 2015 Sep 8;85(10):881–889.
  • Brinjikji W, Rabinstein AA, Nasr DM, et al. Better outcomes with treatment by coiling relative to clipping of unruptured intracranial aneurysms in the United States, 2001–2008. AJNR Am J Neuroradiol. 2011;32(6):1071–1075.
  • Hwang JS, Hyun MK, Lee HJ, et al. Endovascular coiling versus neurosurgical clipping in patients with unruptured intracranial aneurysm: a systematic review. BMC Neurol. 2012;12:99.
  • Ruan C, Long H, Sun H, et al. Endovascular coiling vs. surgical clipping for unruptured intracranial aneurysm: a meta-analysis. Br J Neurosurg. 2015;29(4):485–492.
  • Teleb MS, Pandya DJ, Castonguay AC, et al. Safety and predictors of aneurysm retreatment for remnant intracranial aneurysm after initial endovascular embolization. J Neurointerventional Surg. 2014;6(7):490–494.
  • McDonald JS, McDonald RJ, Fan J, et al. Comparative effectiveness of unruptured cerebral aneurysm therapies: propensity score analysis of clipping versus coiling. Stroke J Cereb Circ. 2013;44(4):988–994.
  • Lad SP, Babu R, Rhee MS, et al. Long-term economic impact of coiling vs clipping for unruptured intracranial aneurysms. Neurosurgery. 2013;72(6):1000–1011; discussion 1011–1013.
  • Darsaut TE, Findlay JM, Raymond J, CURES Collaborative Group. The design of the Canadian UnRuptured Endovascular versus Surgery (CURES) trial. Can J Neurol Sci. 2011;38(2):236–241.
  • Alderazi YJ, Shastri D, Kass-Hout T, et al. Flow diverters for intracranial aneurysms. Stroke Res Treat. 2014;2014:e415653.
  • Mine B, Pierot L, Lubicz B. Intrasaccular flow-diversion for treatment of intracranial aneurysms: the Woven EndoBridge. Expert Rev Med Devices. 2014;11(3):315–325.
  • Cebral JR, Mut F, Raschi M, et al. Aneurysm rupture following treatment with flow-diverting stents: computational hemodynamics analysis of treatment. AJNR Am J Neuroradiol. 2011;32(1):27–33.
  • Molyneux AJ, Birks J, Clarke A, et al. The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms: 18 year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT). Lancet. 2015;385(9969):691–697.
  • King JT, Berlin JA, Flamm ES. Morbidity and mortality from elective surgery for asymptomatic, unruptured, intracranial aneurysms: a meta-analysis. J Neurosurg. 1994;81(6):837–842.
  • Raaymakers TW, Rinkel GJ, Limburg M, et al. Mortality and morbidity of surgery for unruptured intracranial aneurysms: a meta-analysis. Stroke J Cereb Circ. 1998;29(8):1531–1538.
  • Juvela S, Lehto H. Risk factors for all-cause death after diagnosis of unruptured intracranial aneurysms. Neurology. 2015;84(5):456–463.
  • Korja M, Lehto H, Juvela S. Lifelong rupture risk of intracranial aneurysms depends on risk factors: a prospective Finnish cohort study. Stroke J Cereb Circ. 2014;45(7):1958–1963.
  • Johnston SC, Zhao S, Dudley RA, et al. Treatment of unruptured cerebral aneurysms in California Editorial comment: unruptured intracranial aneurysms: in search of the best management strategy. Stroke J Cereb Circ. 2001;32(3):597–605.
  • Brinjikji W, Shahi V, Cloft HJ, et al. Could statin use be associated with reduced recurrence rates following coiling in ruptured intracranial aneurysms? AJNR Am J Neuroradiol. 2015;36(11):2104–2107.
  • Tada Y, Wada K, Shimada K, et al. Roles of hypertension in the rupture of intracranial aneurysms. Stroke J Cereb Circ. 2014;45(2):579–586.
  • Moriwaki T, Takagi Y, Sadamasa N, et al. Impaired progression of cerebral aneurysms in interleukin-1beta-deficient mice. Stroke J Cereb Circ. 2006;37(3):900–905.
  • Aoki T, Kataoka H, Morimoto M, et al. Macrophage-derived matrix metalloproteinase-2 and −9 promote the progression of cerebral aneurysms in rats. Stroke J Cereb Circ. 2007;38(1):162–169.
  • Aoki T, Nishimura M, Matsuoka T, et al. PGE(2) -EP(2) signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF-κB. Br J Pharmacol. 2011;163(6):1237–1249.
  • Aoki T, Kataoka H, Ishibashi R, et al. Impact of monocyte chemoattractant protein-1 deficiency on cerebral aneurysm formation. Stroke J Cereb Circ. 2009;40(3):942–951.
  • Kanematsu Y, Kanematsu M, Kurihara C, et al. Critical roles of macrophages in the formation of intracranial aneurysm. Stroke J Cereb Circ. 2011;42(1):173–178.
  • Aoki T, Kataoka H, Shimamura M, et al. NF-kappaB is a key mediator of cerebral aneurysm formation. Circulation. 2007;116(24):2830–2840.
  • Kimura N, Shimizu H, Eldawoody H, et al. Effect of olmesartan and pravastatin on experimental cerebral aneurysms in rats. Brain Res. 2010;1322:144–152.
  • Aoki T, Kataoka H, Ishibashi R, et al. Simvastatin suppresses the progression of experimentally induced cerebral aneurysms in rats. Stroke J Cereb Circ. 2008;39(4):1276–1285.
  • Aoki T, Kataoka H, Ishibashi R, et al. Pitavastatin suppresses formation and progression of cerebral aneurysms through inhibition of the nuclear factor kappaB pathway. Neurosurgery. 2009;64(2):357–365; discussion 365–366.
  • Tada Y, Kitazato KT, Yagi K, et al. Statins promote the growth of experimentally induced cerebral aneurysms in estrogen-deficient rats. Stroke J Cereb Circ. 2011;42(8):2286–2293.
  • Stehbens WE. Etiology of intracranial berry aneurysms. J Neurosurg. 1989;70(6):823–831.
  • Bruno G, Todor R, Lewis I, et al. Vascular extracellular matrix remodeling in cerebral aneurysms. J Neurosurg. 1998;89(3):431–440.
  • Caird J, Napoli C, Taggart C, et al. Matrix metalloproteinases 2 and 9 in human atherosclerotic and non-atherosclerotic cerebral aneurysms. Eur J Neurol. 2006;13(10):1098–1105.
  • Kim SC, Singh M, Huang J, et al. Matrix metalloproteinase-9 in cerebral aneurysms. Neurosurgery. 1997;41(3):642–666; discussion 646–647.
  • Nuki Y, Tsou T-L, Kurihara C, et al. Elastase-induced intracranial aneurysms in hypertensive mice. Hypertension. 2009;54(6):1337–1344.
  • Makino H, Tada Y, Wada K, et al. Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study. Stroke J Cereb Circ. 2012;43(9):2450–2456.
  • Kucia M, Jankowski K, Reca R, et al. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol. 2003;35(3):233–245.
  • Liekens S, Schols D, Hatse S. CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell mobilization. Curr Pharm Des. 2010;16(35):3903–3920.
  • Hoh BL, Hosaka K, Downes DP, et al. Stromal cell-derived factor-1 promoted angiogenesis and inflammatory cell infiltration in aneurysm walls. J Neurosurg. 2014;120(1):73–86.
  • Starke RM, Chalouhi N, Jabbour PM, et al. Critical role of TNF-α in cerebral aneurysm formation and progression to rupture. J Neuroinflamm. 2014;11:77.
  • Ishibashi R, Aoki T, Nishimura M, et al. Contribution of mast cells to cerebral aneurysm formation. Curr Neurovasc Res. 2010;7(2):113–124.
  • Fukuda S, Hashimoto N, Naritomi H, et al. Prevention of rat cerebral aneurysm formation by inhibition of nitric oxide synthase. Circulation. 2000;101(21):2532–2538.
  • Marbacher S, Marjamaa J, Bradacova K, et al. Loss of mural cells leads to wall degeneration, aneurysm growth, and eventual rupture in a rat aneurysm model. Stroke J Cereb Circ. 2014;45(1):248–254.
  • Xu Y, Tian Y, Wei H-J, et al. Methionine diet-induced hyperhomocysteinemia accelerates cerebral aneurysm formation in rats. Neurosci Lett. 2011;494(2):139–144.
  • de Rooij NK, Linn FHH, van der Plas JA, et al. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry. 2007;78(12):1365–1372.
  • Jamous MA, Nagahiro S, Kitazato KT, et al. Role of estrogen deficiency in the formation and progression of cerebral aneurysms. Part II: experimental study of the effects of hormone replacement therapy in rats. J Neurosurg. 2005;103(6):1052–1057.
  • Hasan DM, Mahaney KB, Brown RD, et al. Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke J Cereb Circ. 2011;42(11):3156–3162.
  • Gross BA, Rosalind Lai PM, Frerichs KU, et al. Aspirin and aneurysmal subarachnoid hemorrhage. World Neurosurg. 2014;82(6):1127–1130.
  • Chalouhi N, Ali MS, Jabbour PM, et al. Biology of intracranial aneurysms: role of inflammation. J Cereb Blood Flow Metab. 1659–1676;32(9):2012.
  • Hasan D, Hashimoto T, Kung D, et al. Upregulation of cyclooxygenase-2 (COX-2) and microsomal prostaglandin E2 synthase-1 (mPGES-1) in wall of ruptured human cerebral aneurysms: preliminary results. Stroke J Cereb Circ. 2012;43(7):1964–1967.
  • Chalouhi N, Jabbour P, Magnotta V, et al. The emerging role of ferumoxytol-enhanced MRI in the management of cerebrovascular lesions. Mol Basel Switz. 2013;18(8):9670–9683.
  • Xu Y, Tian Y, Wei HJ, et al. Erythropoietin increases circulating endothelial progenitor cells and reduces the formation and progression of cerebral aneurysm in rats. Neurosci. 2011 May 5;181:292–299.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.